Evidence map›Paper›PMID 25253772›Full record

ArticleBlood2014

Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.

Koustav Sarkar, Sanjoy Sadhukhan, Seong-Su Han, Yatin M Vyas

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Plasticity in leukocyte migration during haematopoiesis and inflammation.Journal of muscle research and cell motility · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Compound Heterozygous Variants of theFrontiers in genetics · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Koustav SarkarDivision of Pediatric Hematology-Oncology, University of Iowa Children's Hospital, Iowa City, IA; and Division of Pediatric Hematology-Oncology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.
Sanjoy SadhukhanDivision of Pediatric Hematology-Oncology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.
Seong-Su HanDivision of Pediatric Hematology-Oncology, University of Iowa Children's Hospital, Iowa City, IA; and.
Yatin M VyasDivision of Pediatric Hematology-Oncology, University of Iowa Children's Hospital, Iowa City, IA; and Division of Pediatric Hematology-Oncology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.ORCID http://orcid.org/0000-0002-4595-0267
University of Iowa Stead Family Children’s Hospital · USChildren's Hospital of Pittsburgh · US

Funding

Molecular Pathogenesis of Immune Dysfunction In Wiskott-Aldrich-SyndromeR01AI073561 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VYAS, YATIN M · 2008 to 2012
$1.9M
Epigenetic Regulation by WASP of Human TBX21 Gene Transcription ProgramR01AI084957 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VYAS, YATIN M · 2011 to 2014
$1.5M
NIAID NIH HHS R01 AI073561NIAID NIH HHS R01 AI084957
6 · The paper itself

Abstract

Wiskott-Aldrich syndrome (WAS), an immunodeficiency disorder, and X-linked thrombocytopenia (XLT), a bleeding disorder, both arise from nonsynonymous mutations in WAS, which encodes a hematopoietic-specific WASp. Intriguingly, XLT evolves into WAS in some patients but not in others; yet the biological basis for this cross-phenotype (CP) effect remains unclear. Using human T-helper (TH) cells expressing different disease-causing WAS mutations, we demonstrated that hSWI/SNF-like complexes require nuclear-WASp to execute their chromatin-remodeling activity at promoters of WASp-target, immune function genes during TH1 differentiation. Hot-spot WAS mutations Thr45Met and Arg86Cys, which result in XLT-to-WAS disease progression, impair recruitment of hBRM- but not BRG1-enriched BAF complexes to IFNG and TBX21 promoters. Moreover, promoter enrichment of histone H2A.Z and its catalyzing enzyme EP400 are both impaired. Consequently, activation of Notch signaling, a hBRM-regulated event, and its downstream effector NF-κB are both compromised, along with decreased accessibility of nucleosomal DNA and inefficient transcription-elongation of WASp-target TH1 genes. In contrast, patient mutations Ala236Gly and Arg477Lys that manifest in XLT without progressing to WAS do not disrupt chromatin remodeling or transcriptional reprogramming of TH1 genes. Our study defines an indispensable relationship between nuclear-WASp- and hSWI/SNF-complexes in gene activation and reveals molecular distinctions in TH cells that might contribute to disease severity in the XLT/WAS clinical spectrum.

Indexed as

Cell NucleusCells, CulturedChromosomal Proteins, Non-HistoneDiagnosis, DifferentialGenetic Diseases, X-LinkedHumansMutationPromoter Regions, GeneticTh1 CellsThrombocytopeniaT-LymphocytesTranscription FactorsWiskott-Aldrich SyndromeWiskott-Aldrich Syndrome ProteinChromosomal Proteins, Non-HistoneSWI-SNF-B chromatin-remodeling complexTranscription FactorsWAS protein, humanWiskott-Aldrich Syndrome Protein

Identifiers

PMID25253772
PMCPMC4246038
OpenAlexW1983374348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.